Literature DB >> 33095922

Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic: Management of venom allergen immunotherapy during the COVID-19 outbreak in Spain.

Emilia Martínez-Lourido1, Andrea Otero1, Margarita Armisén1, Carmen Vidal1,2,3.   

Abstract

Entities:  

Year:  2020        PMID： 33095922     DOI： 10.1111/all.14567

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  4 in total

1.  Recent advances and developments in COVID-19 in the context of allergic diseases.

Authors:  Mei Ding; Xiang Dong; Yuan-Li Sun; Milena Sokolowska; Mübeccel Akdis; Willem van de Veen; Ahmet Kursat Azkur; Dilek Azkur; Cezmi A Akdis; Ya-Dong Gao
Journal:  Clin Transl Allergy       Date:  2021-09       Impact factor: 5.657

Review 2. 

Authors:  Margitta Worm; Barbara Ballmer-Weber; Randolf Brehler; Mandy Cuevas; Anna Gschwend; Karin Hartmann; Thomas Hawranek; Wolfram Hötzenecker; Bernhard Homey; Thilo Jakob; Natalija Novak; Julia Pickert; Joachim Saloga; Knut Schäkel; Axel Trautmann; Regina Treudler; Bettina Wedi; Gunter Sturm; Franziska Rueff
Journal:  Allergo J       Date:  2020-12-18

3.  Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19.

Authors:  Merve Erkoç; Betül Özdel Öztürk; Dilşad Mungan; Derya Öztuna; Sevim Bavbek; Yavuz Selim Demirel; Ömür Aydın; Betül Ayşe Sin
Journal:  Asia Pac Allergy       Date:  2022-01-24

4.  Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic.

Authors:  Ilkay Koca Kalkan; Hale Ates; Kurtulus Aksu; Selma Yesilkaya; Musa Topel; Dilek Cuhadar Ercelebi; Suleyman Turkyilmaz; Ali Oncul; Senay Demir
Journal:  World Allergy Organ J       Date:  2021-06-08       Impact factor: 4.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.